Brecanavir
Brecanavir is a protease inhibitor which has been studied for the treatment of HIV.
In December 2006, its developer, GlaxoSmithKline discontinued further development because of insurmountable issues regarding formulation.
Brecanavir is a protease inhibitor which has been studied for the treatment of HIV.
In December 2006, its developer, GlaxoSmithKline discontinued further development because of insurmountable issues regarding formulation.